Search

Displaying all 3 results
DrugBest match

Inotuzumab ozogamicin

go.drugbank.com/drugs/DB05889
ApprovedInvestigational

Inotuzumab ozogamicin is an antibody-drug conjugate consisting of a humanized IgG4 kappa CD22-targeting monoclonal antibody covalently attached to calicheamicin derivative, N-acetyl-gamma-calicheamicin dimethylhydrazide. The antibody portion of the drug binds to CD22 receptors expressed on leukemic B cells and intra...

  1. Indication

    Relapsed CD22-positive B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

    go.drugbank.com/conditions/DBCOND0165828
    Drugs: Inotuzumab ozogamicin
  2. Indication

    Refractory CD22-positive B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

    go.drugbank.com/conditions/DBCOND0165829
    Drugs: Inotuzumab ozogamicin